Applying a pharma mindset to cannabis product development
Driven by emerging clinical evidence and increasingly favourable regulatory conditions, companies are racing to develop cannabis-based pharmaceuticals for diverse indications. As competition intensifies, Shift Health believes three key trends will continue to shape the medical cannabis industry, namely:
- The convergence of novel plant, extraction and delivery technologies
- Growth in pharmaceutical-grade testing of cannabis/cannabinoid receptor-modulating products
- Nascent, if maturing, market perceptions of the health benefits of cannabis
In this paper, we explore these trends further and consider their implications for bringing novel cannabis-based drugs to market.
Contact us for more information about applying a pharma mindset to cannabis-based development and Shift Health’s track record in this arena.